EGFL6 and colorectal carcinoma: Moreover, anti-EGFL6 antibody EGFL6-E5-IgG showed tumor growth inhibition and significantly influence anti-metastasis property in vivo without affecting wound healing, indicated EGFL6-E5-IgG is worthy of further development as a potential therapeutic agent against CRC.